Patheon buys Puerto Rican rival
Contract pharmaceutical manufacturer Patheon is to buy Puerto Rican rival Mova Pharmaceuticals in a transaction that could be valued as high as $350 million in cash, stock and assumed debt.
Contract pharmaceutical manufacturer Patheon is to buy Puerto Rican rival Mova Pharmaceuticals in a transaction that could be valued as high as $350 million in cash, stock and assumed debt.
The Lab Automation Europe show at London's Kensington Olympia showcased the latest laboratory equipment and technological developments which are featured in a round-up of new apparatus that could prove useful in drug discovery.
Charles River Laboratories of the US and France's genOway have formed a collaboration to market genetically modified research models to research customers in Europe.
High throughput protein (HTP) crystallography is set to undergo key technical developments in which the development of automation in protein expression, protein engineering and crystallisation will provide the accurate screening data that has proved...
German microfluidics company ThinXXS is to exhibit its novel modular design system, the microfluidic construction kit, a lab-on-a-chip (LOC) device that enables researchers to configure required chip functions. The feature is sure to impact on the...
Parexel and Sartorius have been awarded a contract to supply, validate and help operate a biologic manufacturing facility in South Korea, said to be the first of its kind in the country.
Denmark's Chr Hansen is considering breaking up into two separate entities, one focused on food and pharmaceutical ingredients and the other a pharmaceutical pure-play making allergy vaccines and asthma treatments, activities activity currently...
Dutch chemicals and ingredients company DSM is to purchase a stake in North China Pharmaceutical Group in a move that boosts its presence in the country, writes Phil Taylor.